Medtronic Diabetes, Arecor establish collaboration for thermostable insulin

Arecor Therapeutics announced a research collaboration with Medtronic.This new insulin has the potential to bring significant advancements in the current insulin treatment options for a small population of patients who have limited options for controlling their diabetes with traditional therapy. This collaboration has the potential to allow for the continued care of these patients with an insulin that may minimise the need for pump maintenance interventions and expand the utility for physicians, whilst saving healthcare costs.